Eric P Tamm Selected Research

antineoplaston A10 (A 10)

1/2020

Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pre-Diagnostic Period: Implications for Early Detection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric P Tamm Research Topics

Disease

23	Neoplasms (Cancer) 09/2022 - 12/2004
18	Pancreatic Neoplasms (Pancreatic Cancer) 03/2022 - 06/2005
13	Adenocarcinoma 01/2021 - 06/2005
4	Neoplasm Metastasis (Metastasis) 03/2022 - 09/2016
2	Pancreatic Cyst 04/2015 - 10/2009
2	Disease Progression 07/2010 - 03/2006
1	Squamous Cell Carcinoma of Head and Neck 03/2022
1	Hepatocellular Carcinoma (Hepatoma) 03/2022
1	Sarcoma (Soft Tissue Sarcoma) 03/2022
1	Fibrosis (Cirrhosis) 01/2021
1	Drug-Related Side Effects and Adverse Reactions 12/2020
1	Cysts 12/2016
1	Carcinoid Tumor (Carcinoid) 09/2016
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2016
1	Pathologic Constriction (Stenosis) 07/2013
1	Adrenocortical Carcinoma 12/2007
1	Hemorrhage 03/2006
1	Lymphadenopathy 03/2006
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2004

Drug/Important Bio-Agent (IBA)

4	Gemcitabine FDA Link 01/2020 - 07/2008
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 09/2016
3	IodineIBA 01/2022 - 01/2016
3	Tumor Biomarkers (Tumor Markers)IBA 10/2009 - 10/2005
2	Phosphorus-32IBA 01/2020 - 05/2019
2	DNA (Deoxyribonucleic Acid)IBA 11/2014 - 04/2014
1	hafnium oxideIBA 03/2022
1	antineoplaston A10 (A 10)IBA 01/2020
1	Syntex adjuvant formulationIBA 01/2020
1	130-nm albumin-bound paclitaxelIBA 01/2020
1	folfirinoxIBA 01/2019
1	AntigensIBA 01/2018
1	GadoliniumIBA 09/2016
1	Pentetic Acid (DTPA)FDA LinkGeneric 09/2016
1	gadolinium ethoxybenzyl DTPA FDA Link 09/2016
1	Contrast MediaIBA 04/2016
1	Secretin FDA Link 04/2015
1	Pharmaceutical PreparationsIBA 11/2014
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 04/2014
1	BilirubinIBA 07/2013
1	Complement System Proteins (Complement)IBA 04/2013
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 07/2010
1	CarbohydratesIBA 07/2010
1	Cisplatin (Platino)FDA LinkGeneric 07/2008
1	MetalsIBA 07/2008
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2007
1	Mitotane (Lysodren)FDA Link 12/2007
1	Bevacizumab (Avastin)FDA Link 03/2006
1	Capecitabine (Xeloda)FDA Link 03/2006
1	Indicators and Reagents (Reagents)IBA 12/2004
1	Glucose (Dextrose)FDA LinkGeneric 12/2004
1	Imatinib Mesylate (Gleevec)FDA Link 12/2004

Therapy/Procedure

10	Therapeutics 01/2022 - 08/2006
6	Neoadjuvant Therapy 09/2022 - 07/2010
6	Drug Therapy (Chemotherapy) 01/2020 - 10/2005
4	Pancreaticoduodenectomy 01/2017 - 10/2005
3	Radiotherapy 03/2022 - 06/2005
2	Brachytherapy 01/2020 - 05/2019
1	Duration of Therapy 03/2022
1	Lymph Node Excision (Lymph Node Dissection) 01/2022
1	Decompression 07/2008
1	Stents 07/2008
1	Palliative Care (Palliative Therapy) 06/2005
1	Aftercare (After-Treatment) 12/2004